After reports of contamination in cough syrups sent from the country, India is considering a system to test them before exporting. It is learnt that the Central Drugs Standard Control Organisation (CDSCO) has sent a proposal to the Union health ministry on this. The idea is to test the medicines at government labs before exporting.

Drug sale volumes are almost stuck at pre-pandemic levels but price growth has improved value, data from market research agency Pharmarack AWACS showed. The Indian pharmaceutical market's (IPM) volumes in April 2023 grew by 0.21 per cent when compared to April 2019. Key therapy areas like cardiac, anti-diabetic and vitamins recorded negative volume or consumption growth, while respiratory, anti-infectives, and pain and analgesics had positive growth from April 2019 to April this year.

Analysts have predicted a 23 per cent volume growth for the auto segment between FY22 and FY25, riding on the company's differentiated EV and SUV plan. M&M is already a market leader with a 36 per cent share in electric three-wheelers, and its Zaheerabad plant in Telangana is ready to cater to demand. In the farm segment, the company plans to focus on niche electric products.

In the first nine months of financial year 2022-23, India's exports of medical devices have grown by 17 per cent, while imports have declined by around 8 per cent, show the latest data compiled by the Association of Indian Medical Device Industry (AiMeD). However, import of 30 medical devices from China has risen between 25 per cent and 152 per cent during this period, the AiMeD has written to Commerce and Industries Minister Piyush Goyal in March. The AiMeD is an umbrella organisation of medical device makers.

The question is: Will the company have a strong balance sheet to support this massive investment plan?

Dealers across brands are slashing prices by Rs 20,000 to over Rs 1 lakh, depending on the car model.

Hospitals to recover from sluggish Q3; diagnostics' growth rate at pre-Covid levels.

'I understand some people are comfortable getting a Covishield shot as their third dose.'

Serum Institute of India (SII) and Bharat Biotech have also stopped producing the Covishield and Covaxin vaccines respectively.

Even as India's passenger-vehicle sales touched a record high of 3.9 million units in 2022-23, growing 27 per cent over the previous financial year, the country's largest carmaker, Maruti Suzuki India (MSIL), said on Monday uncertainties in the electronic-component supplies might affect production in FY24. MSIL said the shortage of electronic components had some impact on production in FY23. "The company took all possible measures to minimise the impact.

One needs to charge the device every four days, which can provide over 65,000 blood readings and counts.

Maruti Suzuki says it has sold at least one car in 418,000 villages.

Maruti Suzuki India (MSIL) - the market leader in small cars - is eyeing the top spot in the sports utility vehicle (SUV) segment within a year - with a 33 per cent share of the pie. The company has been selling two SUVs - the Brezza and the Grand Vitara - and will start deliveries of the Jimny and the Fronx from March-end, and has set a target of growing its share from the current 11.5 per cent of the SUV market to 33 per cent by the end of 2023-24. The SUV segment is roughly about 42 per cent of the total passenger vehicle market, or around 1.3 million units.

Balkrishna V Doshi, who won the Pritzker Award in 2018 -- which is equivalent to the Nobel Prize in architecture -- passed into the ages this week. Sohini Das recalls an encounter with the the legendary architect, who was posthumously awarded the Padma Vibhushan in this year's Republic Day honours list.

Dealerships, too, are going all out to roll out the red carpet for women.

'We seem to be in a situation where we can do little, and nothing needs to be done anyway.'

The top reason drawing consumers to EVs is lower fuel cost.

The electric Chetak has already sold close to 25,000 units in India, and the European version will be based on the same platform.

While Mercedes-Benz India expects 25 per cent of its India sales to come from EVs in the next four years, BMW says it estimates around 10 per cent of sales to come from those in the near future.

Cummins India will soon start producing fuel-agnostic engine systems at the Tata-Cummins plant in Phaltan in Satara district of Maharashtra, senior officials at Cummins India said. The firm will start limited production by the end of 2023 and mass production will likely begin by 2024, the officials said.